Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 221

1.

Five-Year Longitudinal Brain Volume Change in Healthy Elders at Genetic Risk for Alzheimer's Disease.

Reiter K, Nielson KA, Durgerian S, Woodard JL, Smith JC, Seidenberg M, Kelly DA, Rao SM.

J Alzheimers Dis. 2017;55(4):1363-1377. doi: 10.3233/JAD-160504.

2.

Genetic risk for Alzheimer's disease alters the five-year trajectory of semantic memory activation in cognitively intact elders.

Rao SM, Bonner-Jackson A, Nielson KA, Seidenberg M, Smith JC, Woodard JL, Durgerian S.

Neuroimage. 2015 May 1;111:136-46. doi: 10.1016/j.neuroimage.2015.02.011. Epub 2015 Feb 14.

3.

Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment.

Okonkwo OC, Alosco ML, Jerskey BA, Sweet LH, Ott BR, Tremont G; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2010 Sep;6(5):404-11. doi: 10.1016/j.jalz.2010.02.003.

4.

A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.

Khan W, Giampietro V, Banaschewski T, Barker GJ, Bokde AL, Büchel C, Conrod P, Flor H, Frouin V, Garavan H, Gowland P, Heinz A, Ittermann B, Lemaître H, Nees F, Paus T, Pausova Z, Rietschel M, Smolka MN, Ströhle A, Gallinat J, Vellas B, Soininen H, Kloszewska I, Tsolaki M, Mecocci P, Spenger C, Villemagne VL, Masters CL, Muehlboeck JS, Bäckman L, Fratiglioni L, Kalpouzos G, Wahlund LO, Schumann G, Lovestone S, Williams SC, Westman E, Simmons A; Alzheimer–s Disease Neuroimaging Initiative; AddNeuroMed Consortium, Australian, Imaging, Biomarkers, and Lifestyle Study Research Group; IMAGEN consortium.

J Alzheimers Dis. 2017;56(3):1159-1174. doi: 10.3233/JAD-161097.

5.

Association of White Matter Integrity and Cognitive Functions in Chinese Non-Demented Elderly with the APOE ɛ4 Allele.

Zhang S, Chen Y, Liu Z, Zhang J, Li X, Cui R, Zhang Z.

J Alzheimers Dis. 2015;48(3):781-91. doi: 10.3233/JAD-150357.

PMID:
26402101
6.

Differential 5-year brain atrophy rates in cognitively declining and stable APOE-ε4 elders.

Kelly DA, Seidenberg M, Reiter K, Nielson KA, Woodard JL, Smith JC, Durgerian S, Rao SM.

Neuropsychology. 2018 Sep;32(6):647-653. doi: 10.1037/neu0000444. Epub 2018 Jun 18.

PMID:
29911873
7.

Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease.

Konishi K, Joober R, Poirier J, MacDonald K, Chakravarty M, Patel R, Breitner J, Bohbot VD.

J Alzheimers Dis. 2018;61(4):1493-1507. doi: 10.3233/JAD-170540.

8.

Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.

Wang X, Wang J, He Y, Li H, Yuan H, Evans A, Yu X, He Y, Wang H.

J Alzheimers Dis. 2015;45(3):781-95. doi: 10.3233/JAD-142556.

PMID:
25624419
9.

Precuneus degeneration in nondemented elderly individuals with APOE ɛ4: Evidence from structural and functional MRI analyses.

Chen Y, Liu Z, Zhang J, Chen K, Yao L, Li X, Gong G, Wang J, Zhang Z.

Hum Brain Mapp. 2017 Jan;38(1):271-282. doi: 10.1002/hbm.23359. Epub 2016 Sep 4.

PMID:
27593520
10.

SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging.

Seddighi S, Varma VR, An Y, Varma S, Beason-Held LL, Tanaka T, Kitner-Triolo MH, Kraut MA, Davatzikos C, Thambisetty M.

J Alzheimers Dis. 2018;61(1):401-414. doi: 10.3233/JAD-170557.

11.

Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.

Soldan A, Pettigrew C, Lu Y, Wang MC, Selnes O, Albert M, Brown T, Ratnanather JT, Younes L, Miller MI; BIOCARD Research Team.

Hum Brain Mapp. 2015 Jul;36(7):2826-41. doi: 10.1002/hbm.22810. Epub 2015 Apr 16.

12.

Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults.

Alexander GE, Bergfield KL, Chen K, Reiman EM, Hanson KD, Lin L, Bandy D, Caselli RJ, Moeller JR.

Neurobiol Aging. 2012 Dec;33(12):2723-32. doi: 10.1016/j.neurobiolaging.2012.01.014. Epub 2012 Mar 8.

13.

Apolipoprotein e4 affects topographical changes in hippocampal and cortical atrophy in Alzheimer's disease dementia: a five-year longitudinal study.

Kim YJ, Cho H, Kim YJ, Ki CS, Chung SJ, Ye BS, Kim HJ, Kim JH, Kim ST, Lee KH, Jeon S, Lee JM, Chin J, Kim JH, Na DL, Seong JK, Seo SW.

J Alzheimers Dis. 2015;44(4):1075-85. doi: 10.3233/JAD-141773.

PMID:
25391384
14.

Diffusion Tensor Imaging Predictors of Episodic Memory Decline in Healthy Elders at Genetic Risk for Alzheimer's Disease.

Lancaster MA, Seidenberg M, Smith JC, Nielson KA, Woodard JL, Durgerian S, Rao SM.

J Int Neuropsychol Soc. 2016 Nov;22(10):1005-1015.

15.

Disrupted functional and structural networks in cognitively normal elderly subjects with the APOE ɛ4 allele.

Chen Y, Chen K, Zhang J, Li X, Shu N, Wang J, Zhang Z, Reiman EM.

Neuropsychopharmacology. 2015 Mar 13;40(5):1181-91. doi: 10.1038/npp.2014.302.

16.

Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45-75: Results from the ALFA study.

Rojas S, Brugulat-Serrat A, Bargalló N, Minguillón C, Tucholka A, Falcon C, Carvalho A, Morán S, Esteller M, Gramunt N, Fauria K, Camí J, Molinuevo JL, Gispert JD.

J Cereb Blood Flow Metab. 2018 Feb;38(2):250-261. doi: 10.1177/0271678X17707397. Epub 2017 May 11.

17.

Conscientiousness is Negatively Associated with Grey Matter Volume in Young APOE ɛ4-Carriers.

Kunz L, Reuter M, Axmacher N, Montag C.

J Alzheimers Dis. 2017;56(3):1135-1144. doi: 10.3233/JAD-160854.

PMID:
28106551
18.

White matter microstructure in late middle-age: Effects of apolipoprotein E4 and parental family history of Alzheimer's disease.

Adluru N, Destiche DJ, Lu SY, Doran ST, Birdsill AC, Melah KE, Okonkwo OC, Alexander AL, Dowling NM, Johnson SC, Sager MA, Bendlin BB.

Neuroimage Clin. 2014 Apr 21;4:730-42. doi: 10.1016/j.nicl.2014.04.008. eCollection 2014.

19.

Tract Based Spatial Statistic Reveals No Differences in White Matter Microstructural Organization between Carriers and Non-Carriers of the APOE ɛ4 and ɛ2 Alleles in Young Healthy Adolescents.

Dell'Acqua F, Khan W, Gottlieb N, Giampietro V, Ginestet C, Bouls D, Newhouse S, Dobson R, Banaschewski T, Barker GJ, Bokde AL, Büchel C, Conrod P, Flor H, Frouin V, Garavan H, Gowland P, Heinz A, Lemaítre H, Nees F, Paus T, Pausova Z, Rietschel M, Smolka MN, Ströhle A, Gallinat J, Westman E, Schumann G, Lovestone S, Simmons A; IMAGEN consortium (http://www.imagen-europe.com).

J Alzheimers Dis. 2015;47(4):977-84. doi: 10.3233/JAD-140519.

PMID:
26401776
20.

Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease.

Honea RA, Swerdlow RH, Vidoni ED, Burns JM.

Neurology. 2011 Mar 1;76(9):822-9. doi: 10.1212/WNL.0b013e31820e7b74.

Supplemental Content

Support Center